Clinical trial
Preoperative Botulinum Toxin A Enables Fascial Closure and Reduces Morbidity in Complex Incisional Hernias: Results From the Prospective
NCT07349628 is registered in ClinicalTrials.gov with Azienda Sanitaria Locale Napoli 2 Nord as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Botulinum Toxin A Enables Fascial Closure and Reduces Morbidity in Complex Incisional Hernias: Results From the Prospective
- Lead sponsor
- Azienda Sanitaria Locale Napoli 2 Nord
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- March 31, 2025
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.